EQUILLIUM, INC. Shareholders' Equity
EQUILLIUM, INC. (EQ) had Shareholders' Equity of $56.02 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $56.02M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $59.49M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $28.60M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $30.94M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $56.02M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $59.49M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $28.60M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $30.94M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.06M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $10.58M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $19.06M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $23.18M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $22.43M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $21.09M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $22.57M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $24.11M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $26.98M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $29.27M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $31.94M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $28.16M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $40.27M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $52.63M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $66.50M 10-K · filed 2024-03-25 | |
| 2021-09-30 | $75.80M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $84.77M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $91.88M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $69.85M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $78.13M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $30.97M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $36.35M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $41.85M 10-K · filed 2022-03-23 | |
| 2019-09-30 | $48.96M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $54.06M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $59.49M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $64.94M 10-K · filed 2021-03-24 | $64.94M 10-K · filed 2019-03-27 |
| 2018-09-30 | -$10.38M 10-Q · filed 2019-11-12 | -$10.38M 10-Q · filed 2018-11-15 |
| 2018-06-30 | -$5.59M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | -$3.83M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | -$2.25M 10-K · filed 2020-03-26 | -$2.25M 10-Q · filed 2018-11-15 |
| 2017-03-15 | $0.00 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |